Defective proviruses cause T cell reprogramming through promoter exaptation in HIV-1 infection

People living with HIV (PLWH) on antiretroviral therapy (ART) accumulate primarily defective proviral sequences in genomes of often clonally expanded CD4+ HIV-1 target cells. Viral-derived DNA is preferentially found at distinct genomic loci suggesting a selective process driven by integration site-specific crosstalk between viral and host sequences. Focusing on one of the most prominent selected integration loci, the BTB Domain and CNC Homolog 2 ( BACH2 ) gene, we here show evidence for exaptation of provirus-derived regulatory sequences leading to target cell reprogramming during long-term ART. Using a cellular model of BACH2 -integrated proviruses, we find that proviral transcription drives aberrant BACH2 protein levels that escape autoregulatory feedback and impose BACH2-dependent transcriptomic changes. By mimicking these changes in primary CD4+ T lymphocytes, we observe that BACH2 drives reprogramming of cells toward a proliferative, precursor memory-like type. These reprogrammed CD4+ T cells possess traits of immune evasion and cellular survival that are signatures of HIV reservoir cells in PLWH. Inhibition of provirus transcriptional activity can mitigate exaptation, suggesting a strategy to offset HIV-driven differentiation and expansion of CD4+ T cells. Finally, our data suggest that provirus exaptation at the Signal Transducer And Activator of Transcription 5B (STAT5B) selected integration gene drives a contrary, effector-like T cell fate, suggesting a multifaceted impact of exaptation on immune homeostasis. Overall, our data demonstrate that proviruses, even if structurally defective, can modulate target cells through insertional activation of integration genes, a process which we postulate to contribute to the complex immune dysregulation experienced by ART-suppressed PLWH.